The IGF axis and hepatocarcinogenesis

Journal of Clinical Pathology - Molecular Pathology

Volumn 54, Issue 3, 2001, Pages 138-144

  Scharf, J G ^a   Dombrowski, F ^b   Ramadori, G ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Hepatocarcinogenesis; Hepatocellular carcinoma; Insulin like growth factor binding proteins; Insulin like growth factor I receptor; Insulin like growth factor II mannose 6 phosphate receptor; Insulin like growth factors

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SOMATOMEDIN RECEPTOR;

CELL LINE; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; CHICKENS; ENDOPEPTIDASES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LIVER NEOPLASMS; MICE; RATS; RECEPTOR, IGF TYPE 1; RECEPTOR, IGF TYPE 2; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0034972116     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.54.3.138     Document Type: Review

References (99)

1. Insulin-like growth factors and cancer
2. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth
3. Molecular and cellular aspects of the insulin-like growth factor I receptor
4. The IGF-I receptor in cancer research
5. Type-2 IGF receptor: A multi-ligand binding protein
6. Imprinted genes in liver carcinogenesis
7. Insulin-like growth factors and their binding proteins: Biological actions
8. Insulin-like growth factor binding proteins
9. Insulin-like growth factor binding proteins and their role in controlling IGF actions
10. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6)
11. Insulin-like growth factor binding protein (IGFBP) proteolysis: Occurrence, identification, role and regulation
12. Regulation of insulin-like growth factor-I and -II by glucose in primary cultures of fetal rat hepatocytes
13. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
14. Normal growth and development in the absence of hepatic insulin-like growth factor I
15. Rat hepatocyte insulin-like growth factor I and binding protein: Effect of growth hormone in vitro and in vivo
16. Production of insulin-like growth factor I and its binding protein by adult rat hepatocytes in primary culture
17. The differential regulation by glucagon and growth hormone of insulin-like growth factor (IGF)-I and IGF binding proteins in cultured rat hepatocytes
18. Characterization of the IGF axis components in isolated rat hepatic stellate cells
19. Regulation of the components of the 150 kDa IGF binding protein complex in cocultures of rat hepatocytes and Kupffer cells by 3′,5′-cyclic adenosine monophosphate
20. Posttranscriptional regulation of insulin-like growth factor II mRNA
21. Expression of insulin-like growth factor II and receptors for insulin-like growth factor II, insulin-like growth factor I and insulin in isolated and cultured rat hepatocytes
22. Expression of insulin-like growth factor II (IGF-II) and IGF-II, IGF-I and insulin receptors mRNAs in isolated non-parenchymal rat liver cells
23. Nutrition and somatomedin. XXV. Regulation of insulin-like growth factor binding protein-1 in primary cultures of normal rat hepatocytes
24. Insulin regulates the expression of the insulin-like growth factor binding protein 2 mRNA in rat hepatocytes
25. Regulation by insulin-like growth factor (IGF) binding proteins of IGF-II-stimulated glycogenesis in cultured fetal rat hepatocytes
26. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex
27. Coculture of primary rat hepatocytes and nonparenchymal cells permits expression of insulin-like growth factor binding protein-3 in vitro
28. Glucocorticoid regulation of insulin-like growth factor-binding protein-3
29. Cellular localization and hormonal regulation of biosynthesis of insulin-like growth factor binding proteins and of the acid-labile subunit within rat liver
30. Synthesis of insulin-like growth factor binding proteins and of the acid-labile subunit in primary cultures of rat hepatocytes, of Kupffer cells, and in cocultures: Regulation by insulin, insulin-like growth factor, and growth hormone
31. Cell-specific localization of insulin-like growth factor binding protein mRNAs in rat liver
32. Nutrition and somatomedin XXIX. Molecular regulation of IGFBP-1 in hepatocyte primary culture
33. Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein I gene transcription by hormones and provision of amino acids in rat hepatocytes
34. Increased sialic acid density in surface glycoprotein of transformed and malignant cells: A general phenomenon?
35. The biogenesis of the MHC II compartment in human I-cell disease B lymphoblasts
36. Differential synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver
37. A comparison of the insulin and insulin-like growth factor I receptors from rat brain and liver
38. Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal liver
39. Metabolic actions of insulin-like growth factor-I in cultured hepatocytes from adult rats
40. Contribution of Kupffer cells to the biosynthesis of insulin-like growth factor system in rat liver
41. Characterization of insulin-like growth factor (IGF)-I binding sites during in vitro transformation of rat hepatic stellate cells to myofibroblasts
42. Insulin and insulin-like growth factor-1 stimulate proliferation and type 1 collagen accumulation by human hepatic stellate cells: Differential effects on signal transduction pathways
43. Secretion of soluble insulin-like growth factor-II/mannose 6-phosphate receptor by rat tissues in culture
44. Mannose 6-phosphate/insulin-like growth factor II-binding proteins in human serum and urine. Their relation to the mannose 6-phosphate/insulin-like growth factor II receptor
45. Serum form of the rat insulin-like growth factor II/mannose 6-phosphate receptor is truncated in the carboxyl-terminal domain
46. Effect of insulin-like growth factor II on uptake of arylsulfatase A by cultured rat hepatocytes and Kupffer cells
47. Radioimmunoassay of soluble insulin-like growth factor-II/mannose 6-phosphate receptor: Developmental regulation of receptor release by rat tissues in culture
48. Transcripts of the insulin-like growth factors I and II in human hepatoma
49. Insulin-like growth factor I in hepatocellular carcinoma and metastatic liver cancer in men
50. Expression of insulin-like growth factor-I (IGF-I) and IGF-II mRNA during hepatic development, proliferation and carcinogenesis in the rat
51. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth
52. Loss of heterozygosity of imprinted genes in SV 40 t/T antigen-induced hepatocellular carcinomas
53. Analysis of insulin-like growth factor II (IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizing in situ hybridization and immunocytochemistry
54. Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers
55. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis
56. Reactivation of the maternally imprinted IGF2 allele in TGF alpha induced hepatocellular carcinomas in mice
57. Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis
58. Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level
59. Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma
60. Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma
61. Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver
62. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease
63. Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma
64. Expression of insulin-like growth factor II in hepatitis B, cirrhosis and hepatocellular carcinoma: Its relationship with hepatitis B virus antigen expression
65. Differential expression of transforming growth factor alpha and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma
66. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma
67. Hepatitis C virus replication is associated with expression of transforming growth factor-alpha and insulin-like growth factor-II in cirrhotic livers
68. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4
69. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma
70. Antisense oligodeoxynucleotides of IGF-II selectively inhibit growth of human hepatoma cells overproducing IGF-II
71. The expression of insulin-like growth factor binding proteins in human hepatocellular carcinoma
72. Altered expression of members of the IGF-axis in hepatoblastomas
73. Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC)
74. Down-regulation of insulin-like growth factor binding proteins and growth modulation in hepatoma cells by retinoic acid
75. Insulin-like growth factor-I effect on chicken hepatoma cells (LMH) is inhibited by endogenous IGF-binding proteins
76. Identification and characterization of genes associated with human hepatocellular carcinogenesis
77. Increased plasma cathepsin D concentration in hepatic carcinoma and cirrhosis but not in breast cancer
78. Cathepsin D, B and L circulating levels as prognostic markers of malignant progression
79. Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1
80. Evidence of autocrine regulation in human hepatoma cell lines
81. Insulin and insulin-like growth factor I regulate the same biological functions in HEP-G2 cells via their own specific receptors
82. Expression and regulation of the insulin-like growth factor-1 receptor by growing and quiescent H4IIE hepatoma
83. Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: Implications of IGF-I receptor gene activation by hepatitis B virus X gene product
84. Regulation of mannose 6-phosphate/insulin-like growth factor-II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital
85. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma
86. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors
87. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
88. Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma
89. Imprinted M6p/Igf2 receptor is mutated in rat liver tumors
90. Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations
91. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers
92. Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan
93. Mutational analysis of three tumor suppressor genes in two models of rat hepatocarcinogenesis
94. Pathogenesis of hepatocellular carcinoma: Sequential cellular, molecular, and metabolic changes
95. Hepatocellular neoplasms induced by low-number pancreatic islet transplants in streptozotocin diabetic rats
96. Hyperproliferative liver acini after intraportal islet transplantation in streptozotocin-induced diabetic rats
97. Altered liver acini induced in diabetic rats by portal vein islet isografts resemble preneoplastic hepatic foci in their enzymic pattern
98. Analysis of the IGF axis in preneoplastic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic rats
99. Contributions of hepadnavirus research to our understanding of hepatocarcinogenesis